HomeJAIDS: Journal of Acquired Immune Deficiency Syndromesindex/list_12208_1

JAIDS: Journal of Acquired Immune Deficiency Syndromesindex/list_12208_1

JAIDS: Journal of Acquired Immune Deficiency Syndromesindex/list_12208_1

Bictegravir/Emtricitabine/Tenofovir Alafenamide Efficacy in Participants With Preexisting Primary Integrase Inhibitor Resistance Through 48 Weeks of Phase 3 Clinical Trials

fox news - October 3, 2022

JAIDS: Journal of Acquired Immune Deficiency Syndromesindex/list_12208_1

Safety and Tolerability of Once Daily Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide for Postexposure Prophylaxis After Sexual Exposure

JAIDS: Journal of Acquired Immune Deficiency Syndromesindex/list_12208_1

SARS-CoV-2 Infection Among People Living With HIV Compared With People Without HIV

Most Read

Fast Five Quiz: Prostate Cancer Molecular and Biomarker Analysis

November 8, 2023

Reproductive Technologies Not Tied to Maternal CVD

November 8, 2023

Crossed Wires: Ischemia Testing and Monomorphic VT Storm

November 8, 2023

Cause of Common Gastrointestinal Symptoms in Diabetes?

November 8, 2023